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Supplementary Fig 1. Overall cohort: Kaplan-Meier recurrence-free survival.
Time (months)
  Number at risk
  Group: Carboplatin
   28 11 7 5 1 0 0
  Group: Non-carbo
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Supplementary  Fig. 2. Kaplan-Meier local recurrence-free survival analysis by 
chemotherapy regimen.
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Time (months)Number at risk
Group: HD + carboplatin
 13 3 3 3 1 0 0
Group: HD + non-carbo
 9 8 2 1 1 1 0
Group: LD + carbo
 15 8 4 2 0 0 0
Group: LD + Non-carbo
 1 0 0 0 0 0 0
Radiation and chemo
 HD + carboplatin
 HD + non-carbo
 LD + carboplatin 
 LD + non-carbo
 
p=0.0846
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Supplementary Fig. 3. Kaplan-Meier local recurrence-free survival analysis by chemoradiotherapy regimen.





8/12 (66.7%)                 
16/19 (84.2%)
p (Fisher exact test*)
 0.3839 








14/21 (66.7%)                
10/10 (100%)
 0.0661 

















*Fisher exact test analysis omits the data where information not documented. TUR: transurethral resection.

















Associated with local recurrence
Independent of local recurrence
11/13 (84.6%)
2/13 (15.4%)
Supplementary Table 3. Toxicities by chemotherapy 
regimen
Toxicity















FET: Fisher exact test.
